The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...

BOSTON — The Endocrine Society has issued a new scientific statement advising clinicians to avoid using custom-compounded hormones to treat menopausal symptoms, female sexual dysfunction, and thyroid ...

Visit NAP.edu/10766 to get more information about this book, to buy it in print, or to download it as a free PDF. The U.S. Food and Drug Administration (FDA) has approved dozens of hormone therapy ...

NATIONAL HARBOR, Maryland — Anywhere from 1 million to 2.5 million women in the United States — about 2% of the female population older than 40 years — are using "bioidentical" compounded menopausal ...

The American Diabetes Association (ADA) urged healthcare providers against prescribing non-FDA approved compounded GLP-1 and dual GIP/GIP-1 receptor agonists for type 2 diabetes or obesity and instead ...

When going through perimenopause and menopause, you’ll likely experience hot flashes, mood swings and other symptoms. This is because your body is changing and your hormone levels are fluctuating. To ...

Hormone therapy is the gold standard for treating VMS, but requires careful patient selection and shared decision-making. Timing, dose, and formulation of hormone therapy are crucial for safety and ...

WASHINGTON — Government health officials have begun cracking down on Internet sales of custom-mixed hormones for menopausal women, a market born when doctors deemed prescription estrogen therapy too ...

CHICAGO -- The use of hormone therapy for menopause in the U.S. has remained low since 2007 when it first dropped, according to an analysis of insurance claims data. The prevalence of hormone therapy ...

Welcome to the Perimenopause Playbook—your guide to navigating the most overlooked and misunderstood phase of the menopausal transition. Read the rest of the stories, from how to get a diagnosis to ...

Misinformation around menopause is still frustratingly common—among both doctors and patients. We asked experts why you shouldn't believe these five myths. While nearly half the world will contend ...

Sabrina Martucci Johnson, President & Chief Executive Officer, highlighted a "recently announced expanded business strategy leveraging a dual path strategy where we commercialize our proprietary ...